ALDER BIOPHARMACEUTICALS INC

Filing date
2018-04-18
Submission
0001209191-18-025410.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Lavelle Erin [ Officer, Chief Commercial Officer, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)14.552018-04-164A : Grant / awardFalse3000000.00A2028-04-15300000Common Stock300000D
Filing date
2018-04-18
Submission
0001209191-18-025405.nc
Form
3 Ownership: Initial statement of beneficial ownership of securities. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Lavelle Erin [ Officer, Chief Commercial Officer, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Non-Derriv. holdingNo securities are beneficially owned.0D
Filing date
2018-03-27
Submission
0001209191-18-021826.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Cleveland Paul B [ Director, Officer, Interim President and CEO, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)11.952018-03-264A : Grant / awardFalse1000000.00A2028-03-25100000Common Stock100000D
Filing date
2018-03-23
Submission
0001425738-18-000020.nc
Form
SC 13D Acquisition of beneficial ownership of 5% or more of any class of equity securities. Includes: Buy / Acquire / Sell / Dispose 1% or more. Incl: Takeovers, change of control
Filing date
2018-02-21
Submission
0001209191-18-012036.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Litton Mark James [ Officer, Chief Business Officer, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)13.552018-02-164A : Grant / awardFalse750000.00A2028-02-1575000Common Stock75000D
Filing date
2018-02-21
Submission
0001209191-18-012055.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Bucher James B [ Officer, Sr. VP & General Counsel, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)13.552018-02-164A : Grant / awardFalse700000.00A2028-02-1570000Common Stock70000D
Filing date
2018-02-21
Submission
0001209191-18-012043.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Schatzman Randall C [ Director, Officer, President and CEO, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)13.552018-02-164A : Grant / awardFalse2000000.00A2028-02-15200000Common Stock200000D
Filing date
2018-02-21
Submission
0001209191-18-012047.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Sandoval Elisabeth [ Officer, CCO & EVP, Corporate Strategy, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)13.552018-02-164A : Grant / awardFalse600000.00A2028-02-1560000Common Stock60000D
Filing date
2018-02-21
Submission
0001209191-18-012045.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Latham John A [ Officer, Chief Scientific Officer, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)13.552018-02-164A : Grant / awardFalse600000.00A2028-02-1560000Common Stock60000D
Filing date
2018-02-21
Submission
0001209191-18-012038.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Hassler Randal [ Officer, EVP, Pharmaceutical Ops., ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)13.552018-02-164A : Grant / awardFalse800000.00A2028-02-1580000Common Stock80000D
Filing date
2018-02-21
Submission
0001209191-18-012041.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Smith Jeffrey T L [ Officer, Managing Director, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)13.552018-02-164A : Grant / awardFalse600000.00A2028-02-1560000Common Stock60000D
Filing date
2018-02-21
Submission
0001209191-18-012049.nc
Form
4 Ownership: Statement of changes in beneficial ownership. Insider trading ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Benedict Larry [ Officer, EVP and PAO, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Derriv. transStock Option (Right to Buy)13.552018-02-164A : Grant / awardFalse600000.00A2028-02-1560000Common Stock60000D
Filing date
2018-02-14
Submission
0001144204-18-008966.nc
Form
SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and institutions
Filing date
2018-02-14
Submission
0001425738-18-000002.nc
Form
SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and institutions
Filing date
2018-02-13
Submission
0001144204-18-007760.nc
Form
SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and institutions
Filing date
2018-02-13
Submission
0001144204-18-007642.nc
Form
SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and institutions
Filing date
2018-02-12
Submission
0000932471-18-004509.nc
Form
SC 13G/A Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and institutions
Filing date
2018-02-09
Submission
0001209191-18-008959.nc
Form
5 Ownership: Annual statement of changes in beneficial ownership of securities. Insider trading. ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Litton Mark James [ Officer, Chief Business Officer, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Non-Derriv. holdingCommon Stock101342D
Non-Derriv. holdingCommon Stock26000IHeld in trust for the benefit of Reporting Person's minor child
Non-Derriv. holdingCommon Stock26000IHeld in trust for the benefit of Reporting Person's minor child
Non-Derriv. holdingCommon Stock26000IHeld in trust for the benefit of Reporting Person's minor child
Filing date
2018-02-09
Submission
0001209191-18-008955.nc
Form
5 Ownership: Annual statement of changes in beneficial ownership of securities. Insider trading. ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Schatzman Randall C [ Director, Officer, President and CEO, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Non-Derriv. holdingCommon Stock116347D
Filing date
2018-02-09
Submission
0001209191-18-008957.nc
Form
5 Ownership: Annual statement of changes in beneficial ownership of securities. Insider trading. ( Directors, Officers, Significant Shareholders )
Issuer
ALDER BIOPHARMACEUTICALS INC ALDR
Reporting Owner
Benedict Larry [ Officer, EVP and PAO, ]
Type Title Conv/Exer price Trans. date Deemed Exe date Trans Form Type Trans Code Eqty swap? Footnote id Trans timelines # Shares Value Total Value Price / share Acq or Disp Date exercisable Expiration date # Owned post trans Value Owned post trans Underlying security title # Underlying securities Value underlying securities Direct or Indirect own Nature indirect own
Non-Derriv. holdingCommon Stock32134D
db